Background: Several factors may influence the progression of normal labour. It has been postulated that the routine administration of intravenous fluids to keep women adequately hydrated during labour may reduce the period of contraction and relaxation of the uterine muscle, and may ultimately reduce the duration of the labour. However, the routine administration of intravenous fluids to labouring women has not been adequately studied although it is widely practiced, and there is no consensus on the type or volume of fluids that are required, or indeed, whether intravenous fluids are at all necessary. This study was conducted to study the effect of intravenous Ringer lactate at 125 ml/hour versus 250 ml/hour on the duration of labour. Methods: In the study, patients were divided in two groups of nulliparous pregnant women in spontaneous early labour (between 3-5 cm dilatation), at term with singleton pregnancy and cephalic presentation, where one group received intravenous Ringer lactate at 125 ml/hour and the other group received Ringer lactate at 250 ml/hour. The duration of labour, mode of delivery and caesarean rates were measured in both groups along with incidence of prolonged labour and need for oxytocin augmentation. Results: The incidence of prolonged labour and oxytocin augmentation were less in the group receiving intravenous RL at 250 ml/hour but was not statistically significant. Remaining outcomes were comparable in both the groups with no outcome reaching statistical significance. Conclusions: Rate of fluid administration is one of the many variables which affects the labour outcomes. The incidence of prolonged labour and oxytocin augmentation was less in the group which received intravenous RL 250 ml/hour. There was no statistically significant difference in both groups in respect of duration of labour, mode of delivery and caesarean rates.
Uncontrolled population growth is a global concern. Adoption of family planning is crucial to limiting the unsustainable growth of the population. This exponential growth of the population puts a large stress on the finite resources worldwide. The magnitude of the burden is further increased in developing and underdeveloped countries where there is a paucity of resources. With majority of population in India in reproductive age group, adoption of family planning methods will not only play an important role in stabilizing the population but will also significantly contribute to the reduction of maternal and neonatal mortality and morbidity. We did the study to determine the prevalence and pattern of contraceptive usage in women attending our OPD in an urban hospital in Shimla, Himachal Pradesh.
Placental mesenchymal dysplasia is a rare placental anomaly characterized by placental enlargement, dilatation and congestion of chorionic plate vessels, and villous edema without signs of trophoblastic proliferation. It is often confused with partial hydatidiform mole. It was first diagnosed in 1991 and the reported incidence is 0.02%. We hereby report a case of a 20 years PGR at a period of gestation 26 weeks 5 days with placental mesenchymal dysplasia. PMD is a rare entity that needs to be distinguished from molar pregnancy to prevent unnecessary termination of pregnancy. Once suspected, these patients should be treated as high-risk pregnancies as they are associated with intrauterine growth restriction (IUGR), intrauterine devices (IUD) and congenital anomalies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.